rs373204728
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000256.3(MYBPC3):c.917G>A(p.Arg306Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000169 in 1,534,606 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.917G>A | p.Arg306Gln | missense_variant | Exon 11 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.917G>A | p.Arg306Gln | missense_variant | Exon 10 of 34 | 5 | ENSP00000382193.2 | |||
MYBPC3 | ENST00000544791.1 | n.917G>A | non_coding_transcript_exon_variant | Exon 11 of 27 | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes AF: 0.0000139 AC: 2AN: 144302Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000307 AC: 7AN: 228156Hom.: 0 AF XY: 0.0000242 AC XY: 3AN XY: 124086
GnomAD4 exome AF: 0.0000173 AC: 24AN: 1390304Hom.: 0 Cov.: 45 AF XY: 0.0000145 AC XY: 10AN XY: 688710
GnomAD4 genome AF: 0.0000139 AC: 2AN: 144302Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 69894
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Arg306Gln varia nt in MYBPC3 has now been identified by our laboratory in one individual with DC M and one individual with HCM. It has also been identified in 1/4036 African Am erican chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washingt on.edu). Arginine (Arg) at position 306 is not evolutionarily conserved and the change to glutamine (Gln) was predicted to be benign using a computational tool clinically validated by our laboratory. This tool's benign prediction is estimat ed to be correct 89% of the time (Jordan 2011). Although these data support that the Arg306Gln variant is more likely benign, additional information is needed t o fully assess the clinical significance of this variant. -
Cardiomyopathy Uncertain:1
This missense variant replaces arginine with glutamine at codon 306 of the MYBPC3 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual affected with hypertrophic cardiomyopathy (PMID: 25351510) and in one individual affected with dilated cardiomyopathy (PMID: 24503780, 27532257). This variant has been identified in 7/228156 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Identified in a patient with cardiomyopathy in published literature (PMID: 27532257); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31983221, 27532257) -
Hypertrophic cardiomyopathy Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 306 of the MYBPC3 protein (p.Arg306Gln). This variant is present in population databases (rs373204728, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of dilated cardiomyopathy (PMID: 27532257). ClinVar contains an entry for this variant (Variation ID: 42802). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at